Blog

The government is finally fighting back against the burgeoning e-cigarette industry as the vping epidemic ravages teens with addiction and a mysterious lung illness that has hospitalized hundreds and claimed multiple lives. On September 9, federal officials at the Food and Drug Administration issued two warning letters to e-cigarette giant JUUL attacking its claims that its e-cigarette products…

A recent wave of plaintiff victories in California trials has brought the safety of the herbicide Roundup into the spotlight of public scrutiny. While its manufacturer, Bayer AG, claims the product is safe, three juries have thought otherwise after being presented with a trove of evidence from both sides of the debate. The plaintiffs…

On May 16th, 2019,  the U.S. Food and Drug Administration (FDA) required Ethicon, a division of Johnson & Johnson, to recall more than 92,000 Circular Staplers that are used in gastrointestinal and bariatric surgeries. The FDA has identified this as a Class I recall, the most serious type of recall. They have stated, “Use of these…

Scientific studies have linked the Zimmer M/L taper and Zimmer M/L taper with Kinectiv technology hip devices to causing dangerous metal poisoning when implanted in the human body. A judge recently awarded $2 million to a man injured by a Zimmer M/L taper hip device with Kinectiv technology at a trial in New Mexico. There are currently several…

On May 6, 2019, New Jersey Federal District Court Judge Robert B. Kugler appointed Goldenberg Lauricella Partner Marlene Goldenberg to the Executive Committee as part of the leadership structure for the Valsartan Multidistrict Litigation (MDL). Marlene has previously served as the head of the discovery committee for the Abilify MDL in the Northern District of Florida…

In 2019, an FDA-mandated study found that patients taking a twice daily 10mg dose of tofacitinib (known by its brand names Xeljanz and Xeljanz XR) may experience an increased risk of developing blood clots in the lungs. The FDA approved tofacitinib for 5mg twice daily use in 2012 and had only approved the drug for use in…